Clinical Trial Update: Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo [Phase 2]

View source ↗

Summary

This is a Phase 2, double-blind, cross-over clinical trial update evaluating the metabolic effects of candesartan, hydrochlorothiazide, and placebo in people wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Drugs mentioned

• Candesartan (candesartan)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Umeå University | Conditions: Hypertension, Obesity | Phase 2 | Status: COMPLETED